SOST and renal cell carcinoma: The mean serum sclerostin level was 37.2 pmol/l (SD 17.8) in RCC patients with localized disease, 44.8 pmol/l (SD 18.5) in RCC patients with bone metastases and 49.7 pmol/l (SD 25.7) in RCC patients with visceral metastases.